Oruka Therapeutics, Inc. (ORKA) insider trading

By person

9 insiders · 127 transactions

145×

Lawrence Klein holds 145 times base salary in stock. $90.84M of shares against $624.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Lawrence Klein last reported holding, valued at $98.40, the price Common Stock was last bought or sold at on the open market here, on 2 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Fairmount Funds Management LLC entity

Director

—

$300.01M (1) scheduled

−$300.01M

1,131,954

1.71%

$111.39M

+77.3%

Lawrence Otto Klein

Chief Executive Officer

—

$11.79M (14) scheduled

−$11.79M

923,128

1.39%

$90.84M

+8.3%

Carl Dambkowski

Director

—

$8.65M (5) scheduled

−$8.65M

38,743

0.0585%

$3.81M

—

Paul T Quinlan

General Counsel

—

$7.47M (18) scheduled

−$7.47M

29,995

0.0453%

$2.95M

—

Arjun Agarwal

Senior Vice President, Finance

—

$5.14M (30) scheduled

−$5.14M

14,219

0.0215%

$1.40M

+437.4%

Joana Goncalves

Chief Medical Officer

—

$5.07M (40) scheduled

−$5.07M

31,771

0.0480%

$3.13M

+1,659%

Laura Lee Sandler

Chief Operating Officer

—

$1.94M (19) scheduled

−$1.94M

235,478

0.3557%

$23.17M

+10.5%

Venrock Healthcare Capital Partners III, L.P. entity

10% owner

—

4,148,428

6.27%

$408.22M

+3.1%

Larry Todd Edwards

Chief Commercial Officer

—

100,000

0.1510%

$9.84M

—

Oruka Therapeutics, Inc.

What the insiders did Mostly scheduled

By person